AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
JMP Securities Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $43
JMP Securities analyst Constantine Davides maintains $Evolent Health(EVH.US)$ with a buy rating, and adjusts the target price from $31 to $43.According to TipRanks data, the analyst has a success
Evolent Health Buy Rating Affirmed With Increased Price Target Amid Growth Prospects and M&A Speculation
Evolent Health (NYSE:EVH) Pulls Back 5.1% This Week, but Still Delivers Shareholders Incredible 33% CAGR Over 5 Years
Here's Why Evolent Health (EVH) Is on the List of Bottom Securities of Carillon Eagle Small Cap Growth Fund
Express News | Evolent Health Inc : Stephens Raises Target Price to $38 From $32